Suchergebnisse - "Virus Diseases"

PubPharm (16.881)

101

The Trend of C-Reactive Protein After Corticosteroid Therapy in COVID-19 Patients Admitted to IGIMS, Patna

enthalten in: Cureus | 2024

von Singh, N. | Kumar, R. | Kumar, S. | +3

102

Safety and Immunogenicity of a Single Dose of the Recombinant Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccines RSV ΔNS2/Δ1313/I1314L, RSV 6120/ΔNS2/1030s, RSV 276 or Placebo, Delivered as Nose Drops to RSV-Seronegative Children 6 to 24 Months of Age : Randomized Phase I/II Study of the Safety and Immunogenicity of a Single Dose of the Recombinant Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccines RSV ΔNS2/Δ1313/I1314L, RSV 6120/ΔNS2/1030s, RSV 276 or Placebo, Delivered as Nose Drops to RSV-Seronegative Children 6 to 24 Months of Age

enthalten in: ClinicalTrials.gov | 2024

103

Trial of Scheduled Versus Treatment Administration of Donor-Derived Viral Specific T-cells for Viral Infections After Stem Cell Transplant : A Randomized Trial of Scheduled Versus Treatment Administration of Donor-Derived Viral Specific T-cells (VSTs) for Control of Viral Infections After Allogeneic Stem Cell Transplant

enthalten in: ClinicalTrials.gov | 2024

104

The potential risk components and prevention measures of the Ebola virus disease outbreak in Liberia : An in-depth interview with the health workers and stakeholders

enthalten in: Belitung nursing journal | 2024

von Stephens, M. | Juniastuti | Sulistiawati | +1

105

Third Party Viral Specific T-cells (VSTs) : Third Party Viral Specific T-cells (VSTs) for Treatment of Viral Infections in Immunocompromised Patients

enthalten in: ClinicalTrials.gov | 2024

106

TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT. : Administration of Most Closely HLA-matched Multivirus-specific Cytotoxic T-Lymphocytes for the Treatment of EBV, CMV, Adenovirus, and BK Virus Infections Post Allogeneic Stem Cell Transplant

enthalten in: ClinicalTrials.gov | 2024

107

Prospective Study of BK Virus Disease After Allogeneic Hematopoietic-cell Transplantation: Defining BK Disease's Natural History, Clinical Spectrum, Immunology, and Outcomes : Prospective Study of BK Virus Disease After Allogeneic Hematopoietic-cell Transplantation: Defining BK Disease's Natural History, Clinical Spectrum, Immunology, and Outcomes

enthalten in: ClinicalTrials.gov | 2024

108

Mucosal Immunity: Influence on Infectious Viral Load: a Prospective Observational Study : Mucosal Immunity: Influence on Infectious Viral Load: a Prospective Observational Study

enthalten in: ClinicalTrials.gov | 2024

109

Prediction of BK Virus Reactivation in Kidney Transplant Recipient : Prediction of BK Virus Infection by Flow Cytometric Analysis of BK Virus-specific T Cell Responses in Kidney Transplant Recipients

enthalten in: ClinicalTrials.gov | 2024

110

Quantum biochemical analysis of the binding interactions between a potential inhibitory drug and the Ebola viral glycoprotein

enthalten in: Journal of biomolecular structure & dynamics | 2024

von da Rocha, J. | Campos, D. | Esmaile, S. | +9